Aerobic and Resistance Exercise in Cancer Patients: Methods and Benefits

Aerobic and Resistance Exercise in Cancer Patients: Methods and Benefits (MS SPOC)

Originally presented October 24, 2018 as part of the UNC Cancer Network Medical and Surgical Oncology Lecture Series. This Self-Paced, Online Course expired November 20, 2019.

This is a Non-Credit course and does NOT offer continuing education credits.

Presenters

Claudio L. Battaglini, PhD, FACSM
Professor, Cancer Prevention and Control
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Bill Wood, MD
Associate Professor, Clinical Research
Leukemia, Lymphoma, and Myeloma Program
Bone Marrow and Stem Cell Transplantation Program
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Aerobic and Resistance Exercise in Cancer Patients: Methods and Benefits

In this presentation, Dr. Wood and Dr. Battaglini will review the importance of physical function (also referred to as physical performance) in patients receiving treatment for cancer, followed by a review of the mechanisms and evidence base supporting the role of exercise in improving cancer outcomes. Examples of aerobic and resistance exercise interventions will be discussed.

Learning Outcomes

  • Discuss the relevance of physical performance in predicting outcomes and the patient experience in individuals who have received treatment for cancer.
  • Differentiate methods for measuring and modeling physical performance in cancer.
  • Describe the benefits that aerobic, resistance, and combined exercise interventions have upon physical performance and outcomes in cancer.
    .

Credits Offered

  • 1.0 ANCC (CNE) hours of study.
  • 1 ASRT Category A CE Credit
  • 1.0 AMA PRA Category 1 Credit™
  • General Participation

Requirements

To receive credit for this course, you must:

  1. Watch a lecture video recording.
  2. Complete the lecture post test and obtain a passing score of 80% or higher.
  3. Complete the course evaluation.
  4. Select credit type.

Estimated course completion time: 1 hour

Disclosures

This activity has been planned and implemented under the sole supervision of the course directors, in association with the UNC Office of Continuing Professional Development (UNC CPD). Dr. Thomas Shea consults for Spectrum Pharma and receives research support from Millennium, Otsuka, GSK, BMS, Novartis and Seattle Genetics. Dr. James Coghill, MD, and CPD staff have no relevant financial relationships with commercial interests as defined by the ACCME.

The speakers, Claudio L. Battaglini, PhD, FACSM, and Bill Wood, MD, have no relevant financial relationships with commercial interests as defined by the ACCME.

Accreditation

This is a Non-Credit course and does NOT offer continuing education credits.

Disclaimer

Please note: This course was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. Questions about personal health should always be referred to a physician or other health care professional.